Supratim Bose
Senior Advisor

Supratim Bose is Executive Vice President and President, Asia-Pacific for Boston Scientific and a member of its Executive Committee. In this role, Supratim oversees the Company’s business and growth opportunities across Asia-Pacific, the world’s fastest growing region. Before joining Boston Scientific in January 2012, Supratim was Founder and Chief Executive Officer of Singapore-based Bose Consulting Group, which specialized in strategic management consulting services for the healthcare industry. Previously, he worked for nearly 30 years at Johnson & Johnson, where he concluded his tenure as Company Group Chairman of its Medical Devices and Diagnostics (MD&D) business. In this role, he managed Johnson & Johnson’s MD&D companies throughout Asia-Pacific, including Japan, having pioneered its entry in all emerging markets in Asia, including China, India, and Vietnam. During his tenure, he also created the company’s research and development capability in the region and led the development and growth of local talent. Prior to J&J, he served at one of the top growing pharmaceutical start-ups in India.

Mr. Bose earned a B.S. in Chemistry/Physics, a M.S. in Biophysics and a Master in Management Studies from the Jamnalal Bajaj Institute of Management Studies at the University of Bombay. He served as a a member of the Board of Directors at Quattro Vascular Pte Ltd and Trireme Medical, and member of the Advisory Board at Singapore Management University’s Lee Kong Chian School of Business. He continues to teach at the Nanyang Business School, Singapore, as a visiting faculty member.

Phil Deschamps
Senior Advisor

Mr. Deschamps offers extensive experience in pharmaceutical and Healthcare commercialization. The depth of his expertise stems from his  25 years in the Health Sciences  industry half of which was spent at Bristol Myers Squibb and half on the service side as CEO of GSW Worldwide, a leading healthcare commercialization company. At GSW, Deschamps was President and CEO and was responsible for the GSW Worldwide operations which includes offices in the 15 major markets around the world with a turnover of $160M.   He primarily consulted on global marketing and commercialization, new business model development for pharmaceutical, device and diagnostics companies. Before joining GSW Worldwide  Deschamps served as director of neuroscience marketing at Bristol- Myers Squibb (BMS) in Princeton, N.J., where he participated on several pre-launch Global Marketing teams in the neuroscience and pain therapeutic areas.  He also held several marketing positions in the neuroscience, pain and metabolic therapeutic areas throughout his career.

Mr. Deschamps recieved a B.S. in Chemistry from the University of Ottowa, Canada

Dennis Donohoe, M.D.
Senior Advisor

Currently, Dr. Donohoe manages a clinical and regulatory consulting service that reviews medical and surgical devices as well as device-drug combination products.  Prior to this he had a long tenure as Johnson & Johnson’s Worldwide Vice President, heading up various clinical, regulatory, cardiology, endovascular, and neurovascular divisions. Among his other accomplishments, he has over 10 years of medical experience in various private and public settings. 

Dr. Donohoe earned his B.A. with honors from LaSalle University, and his M.D. from the Milton S. Hershey Medical Center at Penn State University . 

Robert O'Holla
Senior Advisor

Mr. O’Holla was formerly the Worldwide Vice President of Regulatory Affairs at Johnson & Johnson. Mr. O’Holla is a health products executive that has over thirty years experience, including research and development, quality and compliance, regulatory affairs, policy development, and product sterilization. Mr. O’Holla has also written several publications regarding health products.

Mr. O'Holla received his B.A. from Upsala College, his A.A. from Union College, and his M.B.A. from Fairleigh Dickinson University.

Michael Rechtiene
Senior Advisor

Mr. Rechtiene is a strategic growth leader that builds outstanding growth companies and leadership teams. He has held global medical device leadership positions at Johnson & Johnson including Worldwide President, Animas Corporation and Worldwide General Manager, Therakos Inc. Prior to Therakos he held senior marketing and sales positions at the biotechnology company Centocor and consumer packaged goods leader McNeil Consumer and Specialty Pharmaceuticals. Mr. Rechtiene’s stand for the development of global talent and the shifting of internal mental models has led to radical innovation and unprecedented business and employee engagement improvement results under his leadership. Mr. Rechtiene’s broad academic interests and appointments have included his work as an Advisor to the Center for Global Leadership at the Villanova School of Business and to the SEI Center for Entrepreneurship at the Wharton School of the University of Pennsylvania. Mr. Rechtiene serves as an adjunct faculty member in Marketing at the Wharton School.

Mr. Rechtiene received his undergraduate degree at the Villanova School of Business and his M.B.A. from The Wharton School.

Eric Roth
Senior Advisor

Eric Roth is currently a shareholder at Stearns Weaver Miller, a Florida based law firm.   Mr. Roth previously served as Assistant General Counsel for Johnson & Johnson and Vice President (Law) for Cordis Corporation.
Mr. Roth regularly counsels clients in the life sciences sector and medical device companies, in particular.  He has worked extensively with clients on the development and implementation of healthcare compliance policies and programs and provides clients with training and counseling on topics such as the Anti- Kickback Statute and proper documentation of company interactions with healthcare providers. Mr. Roth has extensive experience in negotiating and documenting clinical trial agreements as well as commercial transactions such as supply, licensing, distribution and strategic alliance agreements with external suppliers, original equipment manufacturers, and strategic partners. He also provides counsel to company management in the areas of corporate compliance, litigation strategy, general commercial matters, pricing and contracting strategies, and product liability issues.

Additionally, Mr. Roth counsels clients on a variety of employment law issues including enforcement of non-competition and non-solicitation agreements, severance and separation agreements, compliance with corporate progressive discipline policies, and discrimination and retaliation claims.

Mr. Roth earned his B.A. from the University of Pennsylvania and his J.D. from the Georgetown University Law Center.

Sandra Thompson
Senior Advisor

Ms. Thompson is a business transformation and innovation expert, working on and with executive teams across healthcare, services, technology and consumer products industries.  Her experience running internal venture businesses, multiple functional areas, and post-acquisition integrations have consistently lead to breakthrough innovations and business and cultural turnarounds.  During her tenure at Johnson & Johnson, Ms. Thompson lead new business ventures for medical device sector in emerging markets, the post-acquisition integration of Animas Corporation into Johnson & Johnson, and strategy and human resources functions at the management board level.  Prior to J&J, Ms. Thompson lead the global marketing transformation efforts at Unisys Corporation,  Human Resources and IT transformation at Caremark Rx, and built an industry leading integrated technology services business.  Ms. Thompson brings a unique blend of human systems expertise, grounded in extensive business leadership success. Ms. Thompson’s results in leadership and culture turnarounds have been recognized as best practices in Training & Development Magazine.

Ms. Thompson undergraduate education is in Psychology and Marketing, and graduate education in Organizational Development and Leadership. She holds master’s certifications in leadership assessments, executive coaching and strategic planning. Ms. Thompson has been a guest lecturer on transformational leadership at leading institutes and Wharton Fellows program.

Marlene Wright Barton
Senior Advisor

Marlene Wright Valenti is currently the President of Wright Regulatory Consulting, LLC in Fort Lauderdale , Florida where she assists medical device companies in developing and executing regulatory strategies.  She has extensive experience in regulatory affairs for Class II and Class III medical devices and has been responsible for worldwide regulatory approvals for Cardiovascular Class II & III combination productions.  Among some of her significant investigational device exemption (IDE) product approvals are the CYPHER^®, the first drug-eluting stent approval for Japan and CHECKMATE, the first brachytherapy system approval for the United States. Additional IDE approvals include products for neurovascular use in the United States , which led to premarket approval.  

Ms. Wright Barton received her B.S. from the State University of New York and Graduate Studies in Business from Empire State College in New York .

Dan Walsh
Senior Advisor

Mr. Walsh is a member of PA Consulting Group’s management team in the life sciences and healthcare practice division.  He leads life sciences technology assignments for a wide range of medical technology, pharmaceutical, and biotechnology clients.  He specializes in technology strategy and acquisition, medical device product development, medical device, diagnostic and pharmaceutical regulatory compliance, quality systems, and improving the effectiveness of commercial launch of new medical technologies.  He has access to the broad capabilities of PA Consulting Group’s global organization.  Mr. Walsh has more than 30 years of product development experience and 20 years in the life sciences industry, including product development, quality and clinical affairs roles for Air-Shields Vickers, Johnson & Johnson IOLAB Site Microsurgical Division, and Moberg Medical. 

Mr. Walsh has a B.S. in Electrical Engineering and an M.S. in Biomedical Engineering.

back to top